Quick Results
Press Releases

Baker Donelson Launches Drug and Device Group

Share

Law360

Author: Abigail Rubenstein

Baker Donelson Bearman Caldwell & Berkowitz PC has established a multidisciplinary drug, device and life sciences industry service team to combine expertise across practice groups.

The 90 member team consists of attorneys who hail from Baker Donelson's health law, product liability, business, intellectual property, and labor and employment practices.

Attorneys from the group will counsel medical device makers, durable medical equipment and supply companies, pharmaceutical and bioscience companies on interaction with the U.S. Food & Drug Administration, mergers and acquisitions, intellectual property disputes, customs, labor and employment issues, government investigations, product liability issues and other litigation matters.

"A balanced complement to our nationally top-ranked health law and product liability practices, this team harnesses our strengths from across the firm, delivering an integrated approach using multidisciplinary teams. While we have already been providing these capabilities to our clients, having a formalized drug, device and life sciences team allows us to provide a robust program that tremendously enhances our client service firmwide," Richard G. Cowart, head of the Baker Donelson's health law department said in a statement.

Baker Donelson has tapped shareholders J. Carter Thompson Jr., who also leads the firm's product liability and mass tort practice group, and Donna K. Thiel, a health care attorney, to co-chair the new group.

News Contact

 
Johanna Burkett
T: 901.577.2201
  Email Professional

Related Professional

Related Practice

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept